Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Omega Healthcare Investors, Inc is a reit—healthcare facilities business based in the US. Omega Healthcare Investors shares (OHI) are listed on the NYSE and all prices are listed in US Dollars. Omega Healthcare Investors employs 49 staff and has a trailing 12-month revenue of around USD$875.3 million.
|52-week range||USD$12.4603 - USD$42.2699|
|50-day moving average||USD$31.4789|
|200-day moving average||USD$30.8862|
|Wall St. target price||USD$34|
|Dividend yield||USD$2.68 (7.77%)|
|Earnings per share (TTM)||USD$0.694|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Omega Healthcare Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Omega Healthcare Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Omega Healthcare Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 50x. In other words, Omega Healthcare Investors shares trade at around 50x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Omega Healthcare Investors's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.13. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Omega Healthcare Investors's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Omega Healthcare Investors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$761.5 million.
The EBITDA is a measure of a Omega Healthcare Investors's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$875.3 million|
|Operating margin TTM||50.66%|
|Gross profit TTM||USD$906 million|
|Return on assets TTM||3.01%|
|Return on equity TTM||4.03%|
|Market capitalisation||USD$7.8 billion|
TTM: trailing 12 months
There are currently 8.0 million Omega Healthcare Investors shares held short by investors – that's known as Omega Healthcare Investors's "short interest". This figure is 13.1% up from 7.0 million last month.
There are a few different ways that this level of interest in shorting Omega Healthcare Investors shares can be evaluated.
Omega Healthcare Investors's "short interest ratio" (SIR) is the quantity of Omega Healthcare Investors shares currently shorted divided by the average quantity of Omega Healthcare Investors shares traded daily (recently around 1.2 million). Omega Healthcare Investors's SIR currently stands at 6.74. In other words for every 100,000 Omega Healthcare Investors shares traded daily on the market, roughly 6740 shares are currently held short.
However Omega Healthcare Investors's short interest can also be evaluated against the total number of Omega Healthcare Investors shares, or, against the total number of tradable Omega Healthcare Investors shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Omega Healthcare Investors's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Omega Healthcare Investors shares in existence, roughly 40 shares are currently held short) or 0.0485% of the tradable shares (for every 100,000 tradable Omega Healthcare Investors shares, roughly 49 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Omega Healthcare Investors.
Find out more about how you can short Omega Healthcare Investors stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Omega Healthcare Investors.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 20.63
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Omega Healthcare Investors's overall score of 20.63 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Omega Healthcare Investors is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 9.42/100
Omega Healthcare Investors's environmental score of 9.42 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Omega Healthcare Investors is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 7.96/100
Omega Healthcare Investors's social score of 7.96 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Omega Healthcare Investors is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.25/100
Omega Healthcare Investors's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Omega Healthcare Investors is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Omega Healthcare Investors scored a 1 out of 5 for controversy – the highest score possible, reflecting that Omega Healthcare Investors has managed to keep its nose clean.
|Total ESG score||20.63|
|Total ESG percentile||14.64|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||1|
Dividend payout ratio: 388.41% of net profits
Recently Omega Healthcare Investors has paid out, on average, around 388.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 7.77% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Omega Healthcare Investors shareholders could enjoy a 7.77% return on their shares, in the form of dividend payments. In Omega Healthcare Investors's case, that would currently equate to about $2.68 per share.
Omega Healthcare Investors's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Omega Healthcare Investors's most recent dividend payout was on 16 November 2020. The latest dividend was paid out to all shareholders who bought their shares by 30 October 2020 (the "ex-dividend date").
Over the last 12 months, Omega Healthcare Investors's shares have ranged in value from as little as $12.4603 up to $42.2699. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Omega Healthcare Investors's is 0.8743. This would suggest that Omega Healthcare Investors's shares are less volatile than average (for this exchange).
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Everything we know about the NewRez IPO, plus information on how to buy in.
Everything we know about the Perella Weinberg IPO, plus information on how to buy in.
Everything we know about the Nanobiotix IPO, plus information on how to buy in.
Everything we know about the Diversey IPO, plus information on how to buy in.
Everything we know about the Certara IPO, plus information on how to buy in.
Everything we know about the Arrival IPO, plus information on how to buy in.
Everything we know about the iSpecimen IPO, plus information on how to buy in.
Everything we know about the IDEX Biometrics ASA IPO, plus information on how to buy in.
Steps to owning and managing MYSZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing MG, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.